Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial

OBJECTIVES: Bench to bedside translation of groundbreaking treatments like chimeric antigen receptor T (CAR-T) cell therapy depends on patient participation in early phase trials. Unfortunately, many novel therapies fail to be adequately evaluated due to low recruitment rates, which slows patient ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo, Gisell, Lalu, Manoj M, Asad, Sarah, Foster, Madison, Kekre, Natasha, Fergusson, Dean A, Hawrysh, Terry, Atkins, Harold, Thavorn, Kednapa, Montroy, Joshua, Schwartz, Stuart, Holt, Robert A, Broady, Raewyn, Presseau, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986876/
https://www.ncbi.nlm.nih.gov/pubmed/33741670
http://dx.doi.org/10.1136/bmjopen-2020-043929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986876/
https://www.ncbi.nlm.nih.gov/pubmed/33741670
http://dx.doi.org/10.1136/bmjopen-2020-043929

Ejemplares similares